Several drugs against Covid-19 already in clinical trials


Nurses wearing protective face masks checking into duty and entering a community hospital in Shanghai. Several antiviral drugs have been applied in clinical trials against the Covid-19 disease (coronavirus), and some have shown fairly good clinical efficacy, according to an official on Saturday (Feb 15). - AFP

BEIJING: Several antiviral drugs have been applied in clinical trials against the Covid-19 disease (coronavirus), and some have shown fairly good clinical efficacy, according to an official on Saturday (Feb 15).

Chinese researchers have narrowed down their focus to a few existing drugs, including Chloroquine Phosphate, Favipiravir and Remdesivir, after multiple rounds of screening, said Zhang Xinmin, director of the China National Centre for Biotechnology Development under the Ministry of Science and Technology, at a press conference on the new virus.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Covid-19. Treatment , Drugs

Next In Regional

OpenAI expects another ‘seismic shock’ from China amid speculation of new DeepSeek release
An app’s blunt life check adds another layer to the loneliness crisis in China
Jailed Chinese AI chatbot developers appeal in landmark pornography case
Singapore, Beijing land in top 10 of Savills’ inaugural Matcha Index of global tech cities
It’s HAL out there: Tencent AI chatbot tells user to ‘get lost’ in rare angry outburst
Alibaba brings visual AI into food fight with China’s Meituan
How Chinese robotaxi giants are steering the Middle East towards a driverless future
Asia-Pacific rides AI boom to unlock tech-empowered growth, cooperation momentum in 2025
China delays plans for mass production of self-driving cars after accident
As US battles China on AI, some companies choose Chinese

Others Also Read